Carmat Archives

Best in Biotech 4 Nov 2022

Get to know 15 of the best biotech companies in Paris

Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15 interesting biotech companies in Paris. Paris is one of the biggest biotech clusters in Europe, with a wide range of applications being developed from drug discovery and medical devices to synthetic biology and green energy. […]

November 4, 2022 - 11 minutesmins - By Omnia Ibrahim

In Depth 1 Mar 2021

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30% of all deaths worldwide. While there are many established treatments on the market, there’s still a need for more effective treatments – can biotech companies provide the answer? We all know that frequent exercise, a […]

March 1, 2021 - 9 minutesmins - By Farhan Mitha

News and Trends 11 Mar 2020

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial heart trial has had the device implanted for 2 years. “Passing a two-year period of individual functioning is very encouraging, and confirms the capacity of our device to provide long-term support, which is one of our two key objectives along […]

March 11, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 21 Feb 2018

Implantation of Carmat’s Artificial Heart Begins in Denmark to Beat Low Enrolment

Carmat’s artificial heart is being tested in patients with heart failure. A hospital in Copenhagen will implant the device, which the biotech hopes will boost patient enrolment to its PIVOTAL trial. Carmat has developed the world’s most advanced fully artificial heart, which has been designed for patients suffering from end-stage biventricular heart failure. The biotech has […]

February 21, 2018 - 3 minutesmins - By Alex Dale

In Depth 17 Jan 2018

An Update on What’s New in the French Biotech Industry

Here’s a closer look at the French biotech ecosystem in 2017, which remains one the leading industries in Europe along with Germany and the UK. France’s biotech ecosystem is relatively dynamic and well-developed. Young companies harboring exciting technology are encouraged into the industry by support from Bpifrance, i-LAB, and iBionext. Once a company gets off the ground, France is […]

January 17, 2018 - 4 minutesmins - By Alex Dale

News and Trends 31 Aug 2016

World’s most advanced Artificial Heart started its last Study before Approval

This artificial heart could replace any defective heart. It’s being developed by the French company Carmat, which just started the last clinical phase before market approval. Carmat is solving one of the life-long problems for humans, how to replace a broken heart. It’s not the first to offer a solution (e.g. Robert Jarvik in the US), […]

August 31, 2016 - 3 minutesmins - By Philip Hemme

News and Trends 1 Mar 2016

Artificial Hearts are one Step Closer to the Market with €50M in Funding

Carmat (France) has raised €50M from private investors (dwarfing its 2015’s €3M reserves) in order to further develop its artificial hearts during 2016 and apply for CE Marking. This French Medtech company is developing an artificial heart (one of top examples of futuristic cyborg-like technologies in biotech) that could help patients with end-stage biventricular heart failure. There are people […]

March 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

Best in Biotech 15 Dec 2015

Becoming Cyborg: 10 Amazing MedTech Inventions in the Biotech Industry

There have been some truly amazing Med-tech developments this year, each sounding like they’re right out of Science fiction (Fringe, anyone?!). Here’s a few seriously worth talking about. Gradually, we too are becoming turning bionic in our attitude to medicine – and due to accessibility of manufacturing platforms, creative innovators like those in the Biohacking […]

December 15, 2015 - 8 minutesmins - By Dani Bancroft

News and Trends 2 Sep 2015

Carmat’s Artificial Heart is now inside three patients – how’s it doing?

So preliminary trial results look good – it could be that the next phase will go forward too. The artificial heart of French pioneer Carmat shows several device failures but overcomes major side effects of former gadgets, such as thromboembolism or haemorrhage. Heart failure is the world’s leading cause of death. In Europe alone, 15 million patients […]

September 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 20 Feb 2015

2014, an amazing year for CARMAT

CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people with irreversible terminal heart failure. This concerns the sickest of the 20 million patients affected by this progressive disease in Europe and the United States. 2014 was an eventful year for the company, the publication of 2014 annual […]

February 20, 2015 - 3 minutesmins - By Joachim Eeckhout

Carmat polemic intelligent artificial heart

News and Trends 24 Sep 2014

The Polemic of First Intelligent Artificial Heart

The first intelligent artificial heart has been twice implanted in France within clinical trials. It has been developed by French company Carmat, and famous cardiologist Alain Carpentier, after 20 years of development. This important breakthrough nevertheless create a polemic. Artificial hearts already existed and voice talks about an artificial financial bubble around Carmat. On September 11th, […]

September 24, 2014 - 4 minutesmins - By Joachim Eeckhout

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us